Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Alzheimer's amyloid-β peptide disturbs P2X7 receptor-mediated circadian oscillations of intracellular calcium.

Wilkaniec A, Schmitt K, Grimm A, Strosznajder JB, Eckert A.

Folia Neuropathol. 2016;54(4):360-368. doi: 10.5114/fn.2016.64813.

2.

Manipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila.

Blake MR, Holbrook SD, Kotwica-Rolinska J, Chow ES, Kretzschmar D, Giebultowicz JM.

Neurobiol Dis. 2015 May;77:117-26. doi: 10.1016/j.nbd.2015.02.012. Epub 2015 Mar 10.

3.

Opposite effects of P2X7 and P2Y2 nucleotide receptors on α-secretase-dependent APP processing in Neuro-2a cells.

León-Otegui M, Gómez-Villafuertes R, Díaz-Hernández JI, Díaz-Hernández M, Miras-Portugal MT, Gualix J.

FEBS Lett. 2011 Jul 21;585(14):2255-62. doi: 10.1016/j.febslet.2011.05.048. Epub 2011 Jun 2.

4.

The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.

Delarasse C, Auger R, Gonnord P, Fontaine B, Kanellopoulos JM.

J Biol Chem. 2011 Jan 28;286(4):2596-606. doi: 10.1074/jbc.M110.200618. Epub 2010 Nov 16.

6.

Ca2+ influx through store-operated Ca2+ channels reduces Alzheimer disease β-amyloid peptide secretion.

Zeiger W, Vetrivel KS, Buggia-Prévot V, Nguyen PD, Wagner SL, Villereal ML, Thinakaran G.

J Biol Chem. 2013 Sep 13;288(37):26955-66. doi: 10.1074/jbc.M113.473355. Epub 2013 Jul 31.

7.

Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.

Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC.

Cell Calcium. 2012 Feb;51(2):95-106. doi: 10.1016/j.ceca.2011.11.008. Epub 2011 Dec 15.

PMID:
22177709
8.

Amyloid-β-Induced Changes in Molecular Clock Properties and Cellular Bioenergetics.

Schmitt K, Grimm A, Eckert A.

Front Neurosci. 2017 Mar 17;11:124. doi: 10.3389/fnins.2017.00124. eCollection 2017.

9.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
10.

Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.

Duncan MJ, Smith JT, Franklin KM, Beckett TL, Murphy MP, St Clair DK, Donohue KD, Striz M, O'Hara BF.

Exp Neurol. 2012 Aug;236(2):249-58. doi: 10.1016/j.expneurol.2012.05.011. Epub 2012 May 22.

PMID:
22634208
11.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
12.

beta-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease.

Barger SW, Smith-Swintosky VL, Rydel RE, Mattson MP.

Ann N Y Acad Sci. 1993 Sep 24;695:158-64. Review.

PMID:
8239276
13.

FAD mutations in amyloid precursor protein do not directly perturb intracellular calcium homeostasis.

Stieren E, Werchan WP, El Ayadi A, Li F, Boehning D.

PLoS One. 2010 Aug 5;5(8):e11992. doi: 10.1371/journal.pone.0011992.

14.

Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.

Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I.

J Alzheimers Dis. 2012;29(3):615-28. doi: 10.3233/JAD-2011-111778.

PMID:
22269161
15.

Calcium dysregulation in Alzheimer's disease.

Bojarski L, Herms J, Kuznicki J.

Neurochem Int. 2008 Mar-Apr;52(4-5):621-33. Epub 2007 Oct 5. Review.

PMID:
18035450
16.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
17.

Effects of amyloid-β peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channels.

Kim S, Rhim H.

Mol Cells. 2011 Sep;32(3):289-94. doi: 10.1007/s10059-011-0075-x. Epub 2011 Aug 4.

18.

Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.

Oulès B, Del Prete D, Greco B, Zhang X, Lauritzen I, Sevalle J, Moreno S, Paterlini-Bréchot P, Trebak M, Checler F, Benfenati F, Chami M.

J Neurosci. 2012 Aug 22;32(34):11820-34.

19.

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.

Zheng W, Xin N, Chi ZH, Zhao BL, Zhang J, Li JY, Wang ZY.

FASEB J. 2009 Dec;23(12):4207-17. doi: 10.1096/fj.09-135749. Epub 2009 Aug 13.

PMID:
19679638
20.

The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease.

Chen KF, Possidente B, Lomas DA, Crowther DC.

Dis Model Mech. 2014 Apr;7(4):445-58. doi: 10.1242/dmm.014134. Epub 2014 Feb 26.

Supplemental Content

Support Center